Literature DB >> 29666307

Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs.

Christina M Rollings1, Linda V Sinclair1, Hugh J M Brady2, Doreen A Cantrell3, Sarah H Ross3.   

Abstract

Interleukin-2 (IL-2) and Janus kinases (JAKs) regulate transcriptional programs and protein synthesis to promote the differentiation of effector CD8+ cytotoxic T lymphocytes (CTLs). Using high-resolution mass spectrometry, we generated an in-depth characterization of how IL-2 and JAKs configure the CTL proteome to control CTL function. We found that IL-2 signaling through JAK1 and JAK3 (JAK1/3) increased the abundance of a key subset of proteins to induce the accumulation of critical cytokines and effector molecules in T cells. Moreover, IL-2 maintained the concentration of proteins that support core metabolic processes essential for cellular fitness. One fundamental insight was the dominant role for IL-2 in stimulating effector T cells to detect microenvironmental cues. IL-2-JAK1/3 signaling pathways thus increased the abundance of nutrient transporters, nutrient sensors, and critical oxygen-sensing molecules. These data provide key insights into how IL-2 promotes T cell function and highlight signaling mechanisms and transcription factors that integrate oxygen sensing to transcriptional control of CD8+ T cell differentiation.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29666307      PMCID: PMC6483062          DOI: 10.1126/scisignal.aap8112

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  52 in total

Review 1.  The E2F transcriptional network: old acquaintances with new faces.

Authors:  Desssislava K Dimova; Nicholas J Dyson
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

Review 2.  IL-2: the first effective immunotherapy for human cancer.

Authors:  Steven A Rosenberg
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

3.  Differential regulation of T-cell growth by IL-2 and IL-15.

Authors:  Georgina H Cornish; Linda V Sinclair; Doreen A Cantrell
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

Review 4.  Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis.

Authors:  Lisa M Lundquist; Sabrina W Cole; Martha L Sikes
Journal:  World J Orthop       Date:  2014-09-18

5.  The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells.

Authors:  Yasutaka Motomura; Hiroshi Kitamura; Atsushi Hijikata; Yuko Matsunaga; Koichiro Matsumoto; Hiromasa Inoue; Koji Atarashi; Shohei Hori; Hiroshi Watarai; Jinfang Zhu; Masaru Taniguchi; Masato Kubo
Journal:  Nat Immunol       Date:  2011-04-03       Impact factor: 25.606

6.  Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo.

Authors:  Vandana Kalia; Surojit Sarkar; Shruti Subramaniam; W Nicholas Haining; Kendall A Smith; Rafi Ahmed
Journal:  Immunity       Date:  2010-01-21       Impact factor: 31.745

7.  Survival factor NFIL3 restricts FOXO-induced gene expression in cancer.

Authors:  Megan Keniry; Maira M Pires; Sarah Mense; Celine Lefebvre; Boyi Gan; Karen Justiano; Ying-Ka Ingar Lau; Ben Hopkins; Cindy Hodakoski; Susan Koujak; Joseph Toole; Franklyn Fenton; Ashley Calahan; Andrea Califano; Ronald A DePinho; Matt Maurer; Ramon Parsons
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 11.361

8.  NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors.

Authors:  Wei Xu; Rita G Domingues; Diogo Fonseca-Pereira; Manuela Ferreira; Hélder Ribeiro; Silvia Lopez-Lastra; Yasutaka Motomura; Lara Moreira-Santos; Franck Bihl; Véronique Braud; Barbara Kee; Hugh Brady; Mark C Coles; Christian Vosshenrich; Masato Kubo; James P Di Santo; Henrique Veiga-Fernandes
Journal:  Cell Rep       Date:  2015-03-19       Impact factor: 9.423

9.  Differentiation of CD8 memory T cells depends on Foxo1.

Authors:  Rodrigo Hess Michelini; Andrew L Doedens; Ananda W Goldrath; Stephen M Hedrick
Journal:  J Exp Med       Date:  2013-05-27       Impact factor: 14.307

10.  Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation.

Authors:  Linda V Sinclair; Julia Rolf; Elizabeth Emslie; Yun-Bo Shi; Peter M Taylor; Doreen A Cantrell
Journal:  Nat Immunol       Date:  2013-03-24       Impact factor: 25.606

View more
  22 in total

1.  T Cell Activation Depends on Extracellular Alanine.

Authors:  Noga Ron-Harel; Jonathan M Ghergurovich; Giulia Notarangelo; Martin W LaFleur; Yoshiki Tsubosaka; Arlene H Sharpe; Joshua D Rabinowitz; Marcia C Haigis
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.423

2.  Intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling and promotes fate decisions, stemness, and protection.

Authors:  Shannon M Kahan; Rakesh K Bakshi; Jennifer T Ingram; R Curtis Hendrickson; Elliot J Lefkowitz; David K Crossman; Laurie E Harrington; Casey T Weaver; Allan J Zajac
Journal:  Sci Immunol       Date:  2022-02-11

3.  Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits.

Authors:  Carly E Whyte; Kailash Singh; James Dooley; Oliver T Burton; Meryem Aloulou; Lubna Kouser; Rafael Valente Veiga; Amy Dashwood; Hanneke Okkenhaug; Samira Benadda; Alena Moudra; Orian Bricard; Stephanie Lienart; Pascal Bielefeld; Carlos P Roca; Francisco José Naranjo-Galindo; Félix Lombard-Vadnais; Steffie Junius; David Bending; Masahiro Ono; Tino Hochepied; Timotheus Y F Halim; Susan Schlenner; Sylvie Lesage; Adrian Liston
Journal:  J Exp Med       Date:  2022-06-14       Impact factor: 17.579

4.  Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.

Authors:  Brendan Zangari; Takemasa Tsuji; Junko Matsuzaki; Hemn Mohammadpour; Cheryl Eppolito; Sebastiano Battaglia; Fumito Ito; Thinle Chodon; Richard Koya; A J Robert McGray; Kunle Odunsi
Journal:  Cancer Immunol Immunother       Date:  2022-04-23       Impact factor: 6.630

5.  Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses.

Authors:  Claire Gorby; Junel Sotolongo Bellón; Stephan Wilmes; Walid Warda; Elizabeth Pohler; Paul K Fyfe; Adeline Cozzani; Christophe Ferrand; Mark R Walter; Suman Mitra; Jacob Piehler; Ignacio Moraga
Journal:  Sci Signal       Date:  2020-09-15       Impact factor: 8.192

6.  Single-cell immune landscape of human atherosclerotic plaques.

Authors:  Dawn M Fernandez; Adeeb H Rahman; Nicolas F Fernandez; Aleksey Chudnovskiy; El-Ad David Amir; Letizia Amadori; Nayaab S Khan; Christine K Wong; Roza Shamailova; Christopher A Hill; Zichen Wang; Romain Remark; Jennifer R Li; Christian Pina; Christopher Faries; Ahmed J Awad; Noah Moss; Johan L M Bjorkegren; Seunghee Kim-Schulze; Sacha Gnjatic; Avi Ma'ayan; J Mocco; Peter Faries; Miriam Merad; Chiara Giannarelli
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440

Review 7.  Regulation of Inflammatory Functions of Macrophages and T Lymphocytes by NFAT5.

Authors:  Jose Aramburu; Cristina López-Rodríguez
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

8.  Antigen receptor control of methionine metabolism in T cells.

Authors:  Linda V Sinclair; Andrew Jm Howden; Alejandro Brenes; Laura Spinelli; Jens L Hukelmann; Andrew N Macintyre; Xiaojing Liu; Sarah Thomson; Peter M Taylor; Jeffrey C Rathmell; Jason W Locasale; Angus I Lamond; Doreen A Cantrell
Journal:  Elife       Date:  2019-03-27       Impact factor: 8.140

9.  Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naïve Versus Effector CD8+ T Cell Transcriptional Programs.

Authors:  Laura Spinelli; Julia M Marchingo; Aneela Nomura; Marcos P Damasio; Doreen A Cantrell
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

10.  Mito-Omics and immune function: Applying novel mitochondrial omic techniques to the context of the aging immune system.

Authors:  Ana R Silverstein; Melanie K Flores; Brendan Miller; Su-Jeong Kim; Kelvin Yen; Hemal H Mehta; Pinchas Cohen
Journal:  Transl Med Aging       Date:  2020-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.